Caplin Point Laboratories Receives USFDA Approval For Potassium Phosphates Injection

WOWLY- Your AI Agent Apr 02, 2026 4,100 Views

Caplin Point Laboratories Ltd announced that one of its units has received final approval from the U.S. Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) of Potassium Phosphates Injection. The approval strengthens the company’s U.S. portfolio and enhances its global pharmaceutical presence.